← back to search

Xizhong Shen

Fudan University · CN
Area of research
Epidemiology · Molecular Biology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Advanced biosensing and bioanalysis techniques, Hepatitis B Virus Studies, and RNA modifications and cancer.
h-index
55
citations
9,184
works
231
NIH funding
primary concept
Medicine
email

Recent publications

Silencing PTPN2 with nanoparticle-delivered small interfering RNA remodels tumor microenvironment to sensitize immunotherapy in hepatocellular carcinoma
Acta Pharmaceutica Sinica B 2025cited by 13position: middledoi
New advances in novel pharmacotherapeutic candidates for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) between 2022 and 2024
Acta Pharmacologica Sinica 2025cited by 10position: middledoi
Targeted delivery of CEBPA-saRNA for the treatment of pancreatic ductal adenocarcinoma by transferrin receptor aptamer decorated tetrahedral framework nucleic acid
Journal of Nanobiotechnology 2024cited by 20position: middledoi
Multi-Omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression microenvironment and hepatocellular carcinoma
International Journal of Biological Sciences 2024cited by 18position: middledoi
Tyrosine kinase receptor B attenuates liver fibrosis by inhibiting TGF-β/SMAD signaling
Hepatology 2023cited by 101position: middledoi
Tyrosine kinase receptor B attenuates liver fibrosis by inhibiting TGF-β/SMAD signaling.
2023cited by 69position: contributordoi
Thalidomide for Recurrent Bleeding Due to Small-Intestinal Angiodysplasia
New England Journal of Medicine 2023cited by 59position: middledoi
Heterogeneous MXene Hybrid-Oriented Exosome Isolation and Metabolic Profiling for Early Screening, Subtyping and Follow-up Evaluation of Bladder Cancer
ACS Nano 2023cited by 33position: middledoi
PRP19 Enhances Esophageal Squamous Cell Carcinoma Progression by Reprogramming SREBF1-Dependent Fatty Acid Metabolism
Cancer Research 2023cited by 30position: middledoi
PRP19 Enhances Esophageal Squamous Cell Carcinoma Progression by Reprogramming SREBF1-Dependent Fatty Acid Metabolism
Cancer Research 2023cited by 28position: contributordoi
CD36-BATF2\MYB Axis Predicts Anti-PD-1 Immunotherapy Response in Gastric Cancer
International Journal of Biological Sciences 2023cited by 26position: middledoi
Coiled-coil domain-containing 154 promotes colorectal cancer proliferation and metastasis via interacting with minichromosome maintenance complex component 2
Cancer Letters 2023cited by 9position: middledoi
Increased expression of autophagy‐related gene 5 indicates poor prognosis in patients with hepatocellular carcinoma
Journal of Digestive Diseases 2023cited by 3position: contributordoi
Double-activation of mitochondrial permeability transition pore opening via calcium overload and reactive oxygen species for cancer therapy
Journal of Nanobiotechnology 2022cited by 96position: middledoi
Perovskite Mediated Vibronic Coupling of Semiconducting SERS for Biosensing
Advanced Functional Materials 2022cited by 48position: middledoi
Pre-mRNA processing factor 19 functions in DNA damage repair and radioresistance by modulating cyclin D1 in hepatocellular carcinoma
Molecular Therapy Nucleic Acids 2022cited by 9position: contributordoi
Prp19 Facilitated p21-Dependent Senescence of Hepatocellular Carcinoma Cells
Journal of Oncology 2022cited by 2position: contributordoi
Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model
Journal of Hepatology 2021cited by 160position: middledoi
Hepatic NOD2 promotes hepatocarcinogenesis via a RIP2-mediated proinflammatory response and a novel nuclear autophagy-mediated DNA damage mechanism
Journal of Hematology & Oncology 2021cited by 98position: middledoi
Tumor cell-imposed iron restriction drives immunosuppressive polarization of tumor-associated macrophages
Journal of Translational Medicine 2021cited by 53position: middledoi
Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis
Hepatology International 2021cited by 39position: middledoi
Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/TSC2 association in hepatocellular carcinoma
Journal of Hepatology 2020cited by 55position: middledoi
Label-Free Analysis of H5N1 Virus Based on Three-Segment Branched DNA-Templated Fluorescent Silver Nanoclusters
ACS Applied Materials & Interfaces 2020cited by 54position: middledoi
Sorafenib-Conjugated Zinc Phthalocyanine Based Nanocapsule for Trimodal Therapy in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model
ACS Applied Materials & Interfaces 2020cited by 44position: middledoi
OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism
Journal of Hepatology 2019cited by 187position: lastdoi
Impaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis
Laboratory Investigation 2019cited by 153position: middledoi
Nanomaterials in Proteomics
Advanced Functional Materials 2019cited by 82position: middledoi
Growth differentiation factor 11 attenuates liver fibrosis via expansion of liver progenitor cells
Gut 2019cited by 67position: middledoi
<p>UBE2T promotes proliferation via G2/M checkpoint in hepatocellular carcinoma</p>
Cancer Management and Research 2019cited by 62position: lastdoi
<p>The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease</p>
Drug Design Development and Therapy 2019cited by 48position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Ling Dong · Beijing University of Chinese Medicine24 papers (2012–2024)Taotao Liu · Sun Yat-sen University18 papers (2012–2025)Ji‐Min Zhu · Fudan University15 papers (2013–2025)Shu‐Qiang Weng · Fudan University11 papers (2014–2024)Guangqi Song · The First Affiliated Hospital, Sun Yat-sen University8 papers (2018–2024)Xiang‐Nan Yu · Fudan University8 papers (2018–2024)Si Zhang · Boston University7 papers (2014–2023)Wenqing Tang · Sun Yat-sen University7 papers (2012–2021)She Chen · Fudan University6 papers (2014–2021)Yanjie Chen · East China University of Science and Technology6 papers (2012–2023)Hao Pei · Chinese Academy of Sciences6 papers (2012–2023)Xuan Shi · Xuzhou Medical College6 papers (2018–2025)Hongying Guo · Zhejiang A & F University5 papers (2018–2024) · 5 papers (2022–2023)Guangcong Zhang · Beijing University of Chemical Technology5 papers (2019–2023)Hao Wu · Fudan University5 papers (2013–2021)Yu‐Dong Cai · Kunming University of Science and Technology4 papers (2012–2017)Xiaowu Huang · Ministry of Education of the People's Republic of China4 papers (2012–2015)Qunyan Yao · Fudan University4 papers (2013–2024)Taoyang Chen · Fudan University4 papers (2013–2015)